Table 4 Outcomes of SVM-based models in predicting distant metastasis for the two validation cohorts
Predicted outcome | Predictive values (%) | ||||||
|---|---|---|---|---|---|---|---|
Models | H | L | Sensitivity | Specificity | PPV | NPV | Accuracy |
Validation cohort ( n =164) | |||||||
SVM1 | 42 | 122 | 44.7 | 90.9 | 81.0 | 65.6 | 69.5 |
SVM2 | 41 | 123 | 44.7 | 92.1 | 82.9 | 65.9 | 70.1 |
SVM3 | 48 | 116 | 55.3 | 93.2 | 87.5 | 70.7 | 75.6 |
SVM4 | 45 | 119 | 56.6 | 97.7 | 95.6 | 72.3 | 78.7 |
Mixed validation cohort ( n =161) | |||||||
SVM1’ | 42 | 119 | 51.7 | 88.4 | 71.4 | 76.5 | 75.2 |
SVM2’ | 58 | 103 | 67.2 | 81.6 | 67.2 | 81.6 | 76.4 |
SVM3’ | 52 | 109 | 67.2 | 87.4 | 75 | 82.6 | 80.1 |
SVM4’ | 50 | 111 | 65.5 | 88.4 | 76 | 82.0 | 80.1 |